Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR2 | O43614 | 10/20 | 0.69 |
| ▸ | HCRTR1 | O43613 | 9/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | MAP3K12 | Q12852 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18697642 | 1.00 | HCRTR2 (0.69) | HCRTR2HCRTR1SMN1; SMN2KDM4ELMNA | |
| SCHEMBL20144919 | 0.86 | HCRTR2 (0.67) | HCRTR2HCRTR1SMN1; SMN2KDM4ELMNA | |
| SCHEMBL20145234 | 0.86 | HCRTR2 (0.67) | HCRTR2HCRTR1SMN1; SMN2KDM4ELMNA | |
| SCHEMBL20145031 | 0.83 | HCRTR2 (0.70) | HCRTR2HCRTR1 | |
| SCHEMBL20144824 | 0.83 | HCRTR2 (0.70) | HCRTR2HCRTR1 | |
| SCHEMBL20144897 | 0.82 | HCRTR2 (0.68) | HCRTR2HCRTR1LMNA | |
| SCHEMBL18697634 | 0.81 | HCRTR2 (0.69) | HCRTR2HCRTR1 | |
| SCHEMBL20144748 | 0.81 | HCRTR2 (0.69) | HCRTR2HCRTR1 | |
| SCHEMBL16031595 | 0.81 | HCRTR1 (1.00) | HCRTR2HCRTR1 | |
| SCHEMBL16030577 | 0.81 | HCRTR1 (1.00) | HCRTR2HCRTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970207-B1 | SUBSTITUTED PIPERIDINE COMPOUNDS AND THEIR USE AS OREXIN RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2018-05-16 | — | — | EP | disclosed |